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Abstract
Amelogenin is critical for enamel formation and human AMELX gene mutations cause hypoplastic
and/or hypomaturation enamel phenotypes. The Amelx null (AKO) mouse has a severe hypoplastic
phenotype. This study evaluated the effect of amelogenin loss on enamel formation and crystallite
morphology. Enamel from AKO and wild type (WT) mice was used. AKO mice were mated with
transgenic mice expressing the most abundant known amelogenin isoform TgM180-87 to rescue
(KOM180-87) the enamel crystallite phenotype. Molar enamel was embedded, sectioned with a
diamond microtome and photographed using transmission electron microscopy. Crystallite sizes
from multiple sections were measured using Image J. Crystallite mean thicknesses were (WT = 26
nm, AKO = 16 nm, KOm180-87 = 25 nm) and the mean widths were (WT = 96 nm, AKO = 59
nm, KOm180-87 = 85 nm). Despite a complete loss of amelogenin in AKO mice, a mineralized
enamel layer with well-defined and organized crystallites forms. Enamel crystallites forming in
the absence of amelogenin were reduced in thickness and width. For the first time we show that
introduction of the m180 amelogenin isoform into the AKO mouse through crossbreeding rescues
the crystallite phenotype. We conclude that amelogenin is essential for the development of normal
crystallite size.
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The enamel extracellular matrix (ECM) is known to be essential for the development of
enamel that has a normal architecture and composition (1). The exact role the different
matrix components play is not fully understood. Amelogenin, the most abundant protein of
the enamel extracellular matrix, is thought to function to as a regulator of crystallite growth
(2). More specifically it has traditionally been thought that amelogenin and the enamel
extracellular matrix help organize crystallite orientation and direction of growth (3). This
has been hypothesized to occur by binding and/or organization of the ECM around the
developing enamel crystallites (4). Earlier reports have suggested that the ECM serves as a
space holder around the developing crystallites and that amelogenin actually inhibits
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crystallite growth (5-6). Directed processing of the enamel proteins is then thought to
regulate crystallite growth specificity by providing control as to face specific growth and
defining the ultimate crystallite morphology (7).
The traditional enamel growth paradigm has been challenged recently (8). Several aspects of
in vivo observations are cited as being inconsistent with the classic enamel crystal growth
theory. As an example, it is noted that enamel crystallites grow in width and thickness
during the secretory phase when most of the ECM remains in place and that even when there
are proteinase deficiencies, such as occur with the loss of MMP20 or KLK4 mutations, the
enamel crystallites still grow in width and thickness (9-10). It has been suggested that the
mineralization front provides shape to the enamel crystallites where thin ribbons of mineral
develop as the precursor and transition to carbonate substituted hydroxyapatite based enamel
crystallites (8). In the absence of enamelin this mineralization front fails to produce these
developing ribbons and organized enamel crystallites do not form (11). If the enamel ECM
is lacking amelogenin, but other enamel proteins are present, this initial enamel mineral
organization does occur (12-13). Amelogenin self assembles into complex three dimensional
structures that are believed to contribute to its role in enamel formation (14-15). Given the
continued controversy over the function and role of the enamel ECM in enamel crystallite
growth, we have undertaken a series of studies to help define the role of amelogenin and its
alternatively spliced products on enamel development. The purpose of this study was to
evaluate the effect of a loss of amelogenin on crystallite size and shape using the amelogenin
knockout mouse as a model.
Materials and Methods
Methods for generating the Amelx null mouse (AKO) and the hypoplastic enamel phenotype
have been described previously (12). Mice were housed in an AAALAC accredited facility
and treated using procedures approved by the University of Pennsylvania Institutional
Animal Care and Use Committee. Male AKO, AKO crossed with TgM180-87 mice, and
Amelx (+/y) mice were used for crystallite size studies. Crossing of the AKO and
TgM180-87 mice produced offspring lacking the native Amelx gene so no alternative spliced
products can be produced but do have an Amelx transgene that produces the most abundant
amelogenin isoform (M180). The rescue mouse line is designated as KOM180-87 with the
87 designating a specific founder and registered as Tg(AMELX*M180)87 (Mouse Genome
Database, The Jackson Laboratory, Bar Harbor, ME, USA).
Enamel was dissected from first molars of the different mice and embedded in epoxy resin.
Multiple ultrathin sections were then cut from each sample and examined using transmission
electron microscopy (JEOL TEM 100CXII). Multiple micrographs were taken from each
section. Multiple crystallites with clearly delineated margins were then measured in each
field using the Image J morphometric software program to establish a mean crystallite width
and thickness. A mean crystallite width and thickness score was generated for each sample
and these means used to test for size difference in each of the mouse models (n = 7 WT, 6 –
AKO and 5 – Rescue mice were evaluated KOM180-87). Differences in crystallite
dimensions were evaluated using ANOVA accepting p ≤ 0.05 as significant and Tukey
Multiple Mean Test.
Results
Well-delineated crystallites were evident in all the different mouse teeth examined using
TEM. There was a range of crystallite sizes seen within each different group of animals and
in any given section. Crystallite thicknesses were typically easier to discern in the
photomicrographs than were crystallite widths. Results of three independent examiners were
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similar so the final data set was limited to the observations of SG. The number of crystallites
measured for each mouse varied depending on quality of sections and images. For example
WT mouse G266 had 71 crystallites measured on 11 different sections while mouse G52 had
11 crystallites measured on two sections. The mean of crystallites measured for each mouse
were then used in the final statistical analysis so the final sample size was the same as the
number of mice as described in the methods section. This approach provided a stringent
statistical evaluation of possible differences in crystallite dimensions for each group of
animals.
Examples of typical TEM micrographs for each of the animal groups are shown (Fig. 1).
The AKO crystallites appeared substantially smaller than the WT and rescue samples (Fig.
1C). While there were areas with crystallites organized parallel to each other in the AKO
mice, they did not have the same degree of organized orientation as seen in the WT or
KOM180-87 rescue mice. The parallel crystallite organization in the rescue mice appeared
similar to that seen in the WT mice as illustrated in Fig. 1.
The mean enamel widths and thicknesses for each genotype are illustrated in Figs. 2 and 3.
The enamel crystallite widths were significantly greater (p = 0.005) in the WT (96 ± 14 nm)
compared with the AKO enamel crystallites (59 ± 11 nm). The rescue mice, KOM180-87,
had enamel crystallite widths (85 ± 25 nm) that were similar to the WT mice and were not
significantly different from the AKO mice (p = 0.079). The crystallite thicknesses were
significantly larger comparing WT (25 ± 5 nm) and KOM180-87 (26 ± 7 nm) with the AKO
enamel crystallites (mean 16 nm ± 4) (p = 0.023 and p = 0.035, respectively). The crystallite
width to thickness ratios were similar for the three groups of animals (WT = 3.8. AKO =
3.7, KOM180-87 = 3.3)
Discussion
Although the exact role of the enamel extracellular matrix molecules during enamel
formation remains controversial, results of the present in vivo study using a transgenic
mouse approach further illustrates the important relationship between the presence of
amelogenin and the enamel crystallite size and orientation. Humans with AMELX associated
amelogenesis imperfecta also have abnormal enamel formation that is in many instances
similar to those changes seen in the various AmelX transgenic mouse models. Collectively
these studies provide ample support for an important role of amelogenin during enamel
formation (12, 16). The specific amelogenin protein alteration seen in these human
conditions ultimately determines the effect on enamel formation and the clinical phenotype
observed, providing further evidence as to critical functional domains in the amelogenin
protein (17). As previously noted, enamel crystallites do form in the absence of amelogenin
producing a thin layer of enamel that is approximately 20 μm thick (12). This is not the case
in the enamelin null mouse (11) and only a very thin mineralized layer is produced when full
length ameloblastin is not secreted by the ameloblasts (18-19). The ability of ameloblasts in
the AmelX KO mouse to generate a thin layer of organized enamel crystallites shows that
amelogenin is not essential to the initial process of enamel mineralization and crystallite
organization while other enamel extracellular matrix proteins such as enamelin are critical.
The present in-vivo study assessing the role of amelogenin in the formation of enamel
crystallites demonstrates that crystallite growth is significantly diminished in the absence of
amelogenin. The diminution in size of the enamel crystallite in the Amelx null mouse
involves all three of its axes causing a reduction in crystallite width, thickness and length
(crystallite length is considered same as enamel thickness from dentin-enamel junction to
enamel surface). Given that the crystallite width to thickness ratio remains the same in WT
and AKO mice it appears that the loss of amelogenin does not alter appositional growth of
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the crystallite with any face specificity. The width to thickness ratio of enamel crystallites is
reported to be 2.6 with the mean width of human crystallites being 68 and the thickness 26
nm (20-21). Crystallite measurements in the present study were similar to those of previous
reports regarding thickness but the width dimension was larger than previously described. In
the present study measurements of the width dimension were more variable than thickness
likely due to the variance in sectioning plane that does not consistently give a true cross
section of the crystallite. Despite this variation in width measurement, the similarity of width
to thickness ratio for crystallites growing in the presence or absence of amelogenin indicate
this abundant ECM protein does not regulate the width to thickness growth ratio. This
observation suggests that binding and regulation of crystallite growth at specific crystallite
faces by amelogenin is not critical for defining the crystallite aspect ratio. It has been
proposed, and in-vitro studies indicate, that amelogenin can help shape crystallite growth
(22-23). The presence of well-delineated crystallites in the AmelX KO mouse indicates that
amelogenin is not critical to prevent crystallite fusion to a major extent as has also been
hypothesized. It also has been proposed that amelogenin helps prevent random proliferation
of mineralization nuclei and help promote the direction of crystallite growth (24). In the
AKO mouse that is completely lacking amelogenin we did not observe the development of
random foci of mineral nucleation. Enamel mineralization appeared to be initiated at the
dentin-enamel junction. It is possible that random foci of mineralization did occur in the
AKO mice at a greater rate than normal after the initial enamel formation but this is difficult
to assess with the methods used in the present study. While initial crystallite orientation at
the dentin enamel junction was ordered, there was a more random order and disorganization
of crystallite directionality just a few microns from the dentin-enamel junction. There was
no evidence of crystallites being organized into a prismatic architecture in the absence of
amelogenin.
The use of the cross matching of AKO and M180 transgenic mice to reintroduce the
amelogenin protein back into the system provides a powerful model to substantiate the
potential role of amelogenin on enamel development and crystallite growth. We show that
replacing the full length amelogenin using this approach essentially fully rescues the enamel
crystallite morphology. This strongly supports that the alteration in crystallite growth is a
direct result of amelogenin protein loss and not from other factors. Crystallite growth was
normalized in the width, thickness and largely in its length with the enamel thickness being
rescued as well (see Gibson et al., this issue). Interestingly, the prism structure was not
typically rescued in the KOM180-87 suggesting that factors other than just the full length
amelogenin could be required to routinely develop this architecture. For example, there
could be alternatively spliced amelogenins that were not replaced in the present model that
are critical for organizing crystallites into prisms. Previous studies suggest that the LRAP
amelogenin isoform could potentially play a role in prism formation (25). Alternatively,
rescue with only the full amelogenin may alter ameloblast – matrix interactions or other
critical processes essential for development of the prismatic architecture.
The present study shows that normal appositional growth of the enamel crystallite is
diminished in the absence of amelogenin. The mechanism for this could be altered crystallite
spacing during the initial development of the first mineral phase adjacent to the dentin-
enamel junction. The absence of amelogenin as a space holder between the developing
enamel mineral ribbons could alter the spatial relationship of the crystallites leading
ultimately to a lack of space to allow for continued crystallite growth. The distance between
mineralizing ribbons of enamel at the dentin-enamel junction is 20 nm (26). Numerous
studies also indicate this is similar in size to the self-assembled amelogenin protein that
forms nanospheres (27). Further TEM analysis of developing enamel crystallites at the
dentin-enamel junction during early secretory stage could help provide answers as to the
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possible function of amelogenin in the separation and organization of early developing
crystallites.
The present study shows that the nascent crystallites orient in a parallel fashion in the
absence of amelogenin and then display a reduced organization as the crystallites grow in
length away from the dentin enamel junction compared with the WT enamel. This indicates
that a parallel orientation of enamel crystallites is not solely mediated by the presence of
amelogenin and that other mechanisms must play a role in crystallite orientation as well.
Studies on the ameloblast enamel matrix interactions continue to suggest a critical role for
normal enamel formation. Even in the absence of amelogenin, a structure similar to that seen
left by the ameloblast Tomes’ process can be seen decorating the enamel surface area of the
teeth (28). Studies suggest ameloblast – matrix interactions are important and new
knowledge in this field continues to emerge such as the identification of a fibronectin
binding domain in ameloblastin (29-30).
In summary, the present study shows well-developed and distinct crystallites are formed in
the complete absence of amelogenin. The complete loss of amelogenin during enamel
development results in a reduction in crystallite growth during initial enamel formation and
crystallites that have the same width to thickness aspect ratio as normal enamel but that are
smaller in dimension. This suggests that amelogenin is a critical determinant of the ultimate
crystallite size but not essential for establishing or maintaining the width to thickness aspect
ratio. The lack of prismatic structure and greatly diminished thickness of enamel in the AKO
mouse shows that amelogenin is essential for the sustained growth in the length of the
crystallites and that it appears to play a critical role in helping to form the complex prismatic
architecture of normal murine enamel.
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Enamel crystallites in the WT mice (A and B) were well-developed and often showed a
parallel organization with respect to adjacent crystallites. In contrast the AKO enamel
crystallites (C) were smaller and less organized than the WT crystallites. The KOM180-87
mouse (D) showed a return to normal crystallite development in both size and with an often
parallel orientation similar to that seen in the WT enamel. (TEMs all exposed at 270K
magnification) (scale bar = 50 nm).
Wright et al. Page 8














The enamel crystallite widths measured from TEM photomicrographs were significantly
reduced in the AKO mice compared with the WT mice. The KOM180-87 mice had widths
that were similar to the WT mice.
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The enamel crystallite thickness was markedly reduced in the AKO mice compared with the
WT enamel. Replacement of amelogenin in the KOM180-87 mice rescued the crystallite
phenotype and allowed development of crystallites with normal thicknesses.
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